Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bo Dupont

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Procedures

Anatomy

Genes & Molecular Sequences

Alleles

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hasan Aisha N; Kollen Wouter J; Trivedi Deepa; Selvakumar Annamalai; Dupont Bo; Sadelain Michel; O'Reilly Richard J
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
Burt Bryan M; Plitas George; Zhao Zeguo; Bamboat Zubin M; Nguyen Hoang M; Dupont Bo; DeMatteo Ronald P
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.
Bioley Gilles; Dousset Christelle; Yeh Alice; Dupont Bo; Bhardwaj Nina; Mears Gregory; Old Lloyd J; Ayyoub Maha; Valmori Danila
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bo Dupont (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hasan Aisha N; Kollen Wouter J; Trivedi Deepa; Selvakumar Annamalai; Dupont Bo; Sadelain Michel; O'Reilly Richard J
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2837-50.
2009: Burt Bryan M; Plitas George; Zhao Zeguo; Bamboat Zubin M; Nguyen Hoang M; Dupont Bo; DeMatteo Ronald P
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(3):1789-96.
2009: Bioley Gilles; Dousset Christelle; Yeh Alice; Dupont Bo; Bhardwaj Nina; Mears Gregory; Old Lloyd J; Ayyoub Maha; Valmori Danila
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4467-74.
2009: Bioley Gilles; Guillaume Philippe; Luescher Immanuel; Yeh Alice; Dupont Bo; Bhardwaj Nina; Mears Gregory; Old Lloyd J; Valmori Danila; Ayyoub Maha
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):299-306.
2008: Shi Jumei; Tricot Guido; Szmania Susann; Rosen Nancy; Garg Tarun K; Malaviarachchi Priyangi A; Moreno Amberly; Dupont Bo; Hsu Katharine C; Baxter-Lowe Lee Ann; Cottler-Fox Michele; Shaughnessy John D; Barlogie Bart; van Rhee Frits
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
British journal of haematology 2008;143(5):641-53.
2008: Diefenbach Catherine S M; Gnjatic Sacha; Sabbatini Paul; Aghajanian Carol; Hensley Martee L; Spriggs David R; Iasonos Alexia; Lee Helen; Dupont Bo; Pezzulli Sandra; Jungbluth Achim A; Old Lloyd J; Dupont Jakob
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2740-8.
2008: Kim Sungjin; Sunwoo John B; Yang Liping; Choi Taewoong; Song Yun-Jeong; French Anthony R; Vlahiotis Anna; Piccirillo Jay F; Cella Marina; Colonna Marco; Mohanakumar Thalachallour; Hsu Katharine C; Dupont Bo; Yokoyama Wayne M
HLA alleles determine differences in human natural killer cell responsiveness and potency.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(8):3053-8.
2007: Chewning Joseph H; Gudme Charlotte N; Hsu Katharine C; Selvakumar Annamalai; Dupont Bo
KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(2):854-68.
2007: Hsu K C; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf E W
Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Tissue antigens 2007;69 Suppl 1():42-5.
2006: Farag Sherif S; Bacigalupo Andrea; Eapen Mary; Hurley Carolyn; Dupont Bo; Caligiuri Michael A; Boudreau Christian; Nelson Gene; Oudshoorn Machteld; van Rood Jon; Velardi Andrea; Maiers Martin; Setterholm Michelle; Confer Dennis; Posch Phillip E; Anasetti Claudio; Kamani Naynesh; Miller Jeffrey S; Weisdorf Daniel; Davies Stella M;
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):876-84.
2006: Hsu Katharine C; Gooley Ted; Malkki Mari; Pinto-Agnello Clara; Dupont Bo; Bignon Jean-Denis; Bornhäuser Martin; Christiansen Frank; Gratwohl Alois; Morishima Yasuo; Oudshoorn Machteld; Ringden Olle; van Rood Jon J; Petersdorf Effie;
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):828-36.
2005: Felner Eric I; Klitz William; Ham Melissa; Lazaro Ana M; Stastny Peter; Dupont Bo; White Perrin C
Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus.
Pediatric diabetes 2005;6(4):213-20.
2005: Hsu Katharine C; Keever-Taylor Carolyn A; Wilton Andrew; Pinto Clara; Heller Glenn; Arkun Knarik; O'Reilly Richard J; Horowitz Mary M; Dupont Bo
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Blood 2005;105(12):4878-84.
2005: Marsh Steven G E; Albert Ekkehard D; Bodmer Walter F; Bontrop Ronald E; Dupont Bo; Erlich Henry A; Geraghty Daniel E; Hansen John A; Hurley Carolyn K; Mach Bernard; Mayr Wolfgang R; Parham Peter; Petersdorf Effie W; Sasazuki Takehiko; Schreuder Geziena M Th; Strominger Jack L; Svejgaard Arne; Terasaki Paul I; Trowsdale John
Nomenclature for Factors of the HLA System, 2004.
Human immunology 2005;66(5):571-636.
2005: Hsu Katharine C; Dupont Bo
Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.
Seminars in hematology 2005;42(2):91-103.
2005: Marsh S G E; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Geraghty D E; Hansen J A; Hurley C K; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M Th; Strominger J L; Svejgaard A; Terasaki P I; Trowsdale J
Nomenclature for factors of the HLA system, 2004.
Tissue antigens 2005;65(4):301-69.
2005: Marsh S G E; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Geraghty D E; Hansen J A; Hurley C K; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M Th; Strominger J L; Svejgaard A; Terasaki P I; Trowsdale J
Nomenclature for factors of the HLA system, 2004.
International journal of immunogenetics 2005;32(2):107-59.
2005: Huang Winifred; Ochs Hans D; Dupont Bo; Vyas Yatin M
The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(5):2602-11.
2004: Dupont Bo; Hsu Katharine C
Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.
Current opinion in immunology 2004;16(5):634-43.
2004: Vyas Yatin M; Maniar Hina; Lyddane Clay E; Sadelain Michel; Dupont Bo
Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):1571-8.
2004: Atanackovic Djordje; Altorki Nasser K; Stockert Elisabeth; Williamson Barbara; Jungbluth Achim A; Ritter Erika; Santiago Darren; Ferrara Cathy A; Matsuo Mitsutoshi; Selvakumar Annamalai; Dupont Bo; Chen Yao-Tseng; Hoffman Eric W; Ritter Gerd; Old Lloyd J; Gnjatic Sacha
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3289-96.
2003: Doubrovina Ekaterina S; Doubrovin Mikhail M; Vider Elena; Sisson Richard B; O'Reilly Richard J; Dupont Bo; Vyas Yatin M
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(12):6891-9.
2003: Zhang Lei; Hsu Katharine C; Liu Xiao-Rong; Yang Jue-qin; Yao Fang-juan; Xu Ling-di; Dupont Bo; Fan Li-an
[Killer Ig-like receptor gene content diversity and haplotype analysis in Chinese Han population in Shanghai]
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2003;20(5):396-9.
2003: Marsh S G E; Parham P; Dupont B; Geraghty D E; Trowsdale J; Middleton D; Vilches C; Carrington M; Witt C; Guethlein L A; Shilling H; Garcia C A; Hsu K C; Wain H
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
Tissue antigens 2003;62(1):79-86.
2003: Gnjatic Sacha; Atanackovic Djordje; Jäger Elke; Matsuo Mitsutoshi; Selvakumar Annamalai; Altorki Nasser K; Maki Robert G; Dupont Bo; Ritter Gerd; Chen Yao-Tseng; Knuth Alexander; Old Lloyd J
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(15):8862-7.
2003: Marsh Steven G E; Parham Peter; Dupont Bo; Geraghty Daniel E; Trowsdale John; Middleton Derek; Vilches Carlos; Carrington Mary; Witt Campbell; Guethlein Lisbeth A; Shilling Heather; Garcia Christian A; Hsu Katharine C; Wain Hester
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
Immunogenetics 2003;55(4):220-6.
2003: Marsh S G E; Parham P; Dupont B; Geraghty D E; Trowsdale J; Middleton D; Vilches C; Carrington M; Witt C; Guethlein L A; Shilling H; Garcia C A; Hsu K C; Wain H
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2003;30(3):229-34.
2003: Marsh Steven G E; Parham Peter; Dupont Bo; Geraghty Daniel E; Trowsdale John; Middleton Derek; Vilches Carlos; Carrington Mary; Witt Campbell; Guethlein Lisbeth A; Shilling Heather; Garcia Christian A; Hsu Katharine C; Wain Hester
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
Human immunology 2003;64(6):648-54.
2002: Hsu Katharine C; Chida Shohei; Geraghty Daniel E; Dupont Bo
The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.
Immunological reviews 2002;190():40-52.
2002: Marsh Steven G E; Albert Ekkehard D; Bodmer Walter F; Bontrop Ronald E; Dupont Bo; Erlich Henry A; Geraghty Daniel E; Hansen John A; Mach Bernard; Mayr Wolfgang R; Parham Peter; Petersdorf Effie W; Sasazuki Takehiko; Schreuder Geziena M T; Strominger Jack L; Svejgaard Arne; Terasaki Paul I
Nomenclature for factors of the HLA system, 2002.
Human immunology 2002;63(12):1213-68.
2002: Marsh Steven G E; Albert Ekkehard D; Bodmer Walter F; Bontrop Ronald E; Dupont Bo; Erlich Henry A; Geraghty Daniel E; Hansen John A; Mach Bernard; Mayr Wolfgang R; Parham Peter; Petersdorf Effie W; Sasazuki Takehiko; Schreuder Geziena M Th; Strominger Jack L; Svejgaard Arne; Terasaki Paul I
Nomenclature for factors of the HLA system, 2002.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2002;29(6):463-515.
2002: Marsh S G E; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Geraghty D E; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M Th; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2002.
Tissue antigens 2002;60(5):407-64.
2002: Vyas Yatin M; Maniar Hina; Dupont Bo
Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses.
Immunological reviews 2002;189():161-78.
2002: Hsu Katharine C; Liu Xiao-Rong; Selvakumar Annamalai; Mickelson Eric; O'Reilly Richard J; Dupont Bo
Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(9):5118-29.
2002: Dupont Bo
Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines.
Immunological reviews 2002;188():5-8.
2002: Vyas Yatin M; Maniar Hina; Dupont Bo
Cutting edge: differential segregation of the SRC homology 2-containing protein tyrosine phosphatase-1 within the early NK cell immune synapse distinguishes noncytolytic from cytolytic interactions.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(7):3150-4.
2002: Koehne Guenther; Smith Katherine M; Ferguson Teresa L; Williams Roxanne Y; Heller Glenn; Pamer Eric G; Dupont Bo; O'Reilly Richard J
Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.
Blood 2002;99(5):1730-40.
2001: Petersdorf E W; Kollman C; Hurley C K; Dupont B; Nademanee A; Begovich A B; Weisdorf D; McGlave P
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Blood 2001;98(10):2922-9.
2001: Vyas Y M; Mehta K M; Morgan M; Maniar H; Butros L; Jung S; Burkhardt J K; Dupont B
Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(8):4358-67.
2001: Marsh S G; Bodmer J G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; MacH B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2000.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2001;28(3):377-424.
2001: Marsh S G; Bodmer J G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2000.
Human immunology 2001;62(4):419-68.
2001: Marsh S G; Bodmer J G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2000.
Tissue antigens 2001;57(3):236-83.
2001: Marti F; Krause A; Post N H; Lyddane C; Dupont B; Sadelain M; King P D
Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):197-206.
2000: Gnjatic S; Nagata Y; Jager E; Stockert E; Shankara S; Roberts B L; Mazzara G P; Lee S Y; Dunbar P R; Dupont B; Cerundolo V; Ritter G; Chen Y T; Knuth A; Old L J
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10917-22.
2000: Jäger E; Nagata Y; Gnjatic S; Wada H; Stockert E; Karbach J; Dunbar P R; Lee S Y; Jungbluth A; Jäger D; Arand M; Ritter G; Cerundolo V; Dupont B; Chen Y T; Old L J; Knuth A
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4760-5.
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA System, 1998.
Human immunology 1999;60(4):361-95.
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1998.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1999;26(2-3):81-116.
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1998.
Tissue antigens 1999;53(4 Pt 2):407-46.
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1998.
Vox sanguinis 1999;77(3):164-91.
1998: Vyas Y; Selvakumar A; Steffens U; Dupont B
Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
Tissue antigens 1998;52(6):510-9.
1998: Connelly R J; Hayden M S; Scholler J K; Tsu T T; Dupont B; Ledbetter J A; Kanner S B
Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.
International immunology 1998;10(12):1863-72.
1998: Dupont B
Induction of a minor into the major league? Genomic identification of a human minor histocompatibility antigen.
Tissue antigens 1998;52(4):303-4.
1998: Marti F; Xu C W; Selvakumar A; Brent R; Dupont B; King P D
LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11810-5.
1998: King P D; Sadra A; Teng J M; Bell G M; Dupont B
CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail.
International immunology 1998;10(7):1009-16.
1998: Steffens U; Vyas Y; Dupont B; Selvakumar A
Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998.
Tissue antigens 1998;51(4 Pt 1):398-413.
1997: Bozón M V; Delgado J C; Selvakumar A; Clavijo O P; Salazar M; Ohashi M; Alosco S M; Russell J; Yu N; Dupont B; Yunis E J
Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods.
Tissue antigens 1997;50(4):387-94.
1997: August A; Sadra A; Dupont B; Hanafusa H
Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11227-32.
1997: Bullard D C; King P D; Hicks M J; Dupont B; Beaudet A L; Elkon K B
Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(4):2058-67.
1997: Small T N; Avigan D; Dupont B; Smith K; Black P; Heller G; Polyak T; O'Reilly R J
Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):65-75.
1997: Dupont B
Immunology of hematopoietic stem cell transplantation: a brief review of its history.
Immunological reviews 1997;157():5-12.
1997: Selvakumar A; Steffens U; Palanisamy N; Chaganti R S; Dupont B
Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103.
Tissue antigens 1997;49(6):564-73.
1997: Dupont B; Selvakumar A; Steffens U
The killer cell inhibitory receptor genomic region on human chromosome 19q13.4.
Tissue antigens 1997;49(6):557-63.
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1996.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1997;24(2):105-51.
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA System, 1996.
Human immunology 1997;53(1):98-128.
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1996.
Tissue antigens 1997;49(3 Pt 2):297-321.
1997: Selvakumar A; Steffens U; Dupont B
Polymorphism and domain variability of human killer cell inhibitory receptors.
Immunological reviews 1997;155():183-96.
1997: King P D; Sadra A; Teng J M; Xiao-Rong L; Han A; Selvakumar A; August A; Dupont B
Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):580-90.
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1996.
Vox sanguinis 1997;73(2):105-30.
1996: Salazar M; Granja C B; Selvakumar A; Fresia B; Alosco S; Dupont B; Yunis E J
New HLA-DR haplotypes containing the DRB6 pseudogene.
Tissue antigens 1996;48(5):575-9.
1996: King P D; Sadra A; Han A; Liu X R; Sunder-Plassmann R; Reinherz E L; Dupont B
CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK.
International immunology 1996;8(11):1707-14.
1996: Selvakumar A; Steffens U; Dupont B
NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains.
Tissue antigens 1996;48(4 Pt 1):285-94.
1996: Teng J M; King P D; Sadra A; Liu X; Han A; Selvakumar A; August A; Dupont B
Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion.
Tissue antigens 1996;48(4 Pt 1):255-64.
1996: Bozón M V; Delgado J C; Turbay D; Salazar M; Granja C B; Alosco S M; Dupont B; Yunis E J
Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing.
Tissue antigens 1996;47(6):512-8.
1996: Dupont B
Human immunogenetics and histocompatibility testing, 1996.
Tissue antigens 1996;47(6):457-9.
1996: Teng J M; Liu X R; Mills G B; Dupont B
CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(9):3222-32.
1996: August A; Dupont B
Association between mitogen-activated protein kinase and the zeta chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck. Differential regulation by TcR cross-linking.
The Journal of biological chemistry 1996;271(17):10054-9.
1996: Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills G B
The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(8):2716-22.
1996: Gibson S; August A; Branch D; Dupont B; Mills G M
Functional LCK Is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK.
The Journal of biological chemistry 1996;271(12):7079-83.
1996: Lucas K G; Small T N; Heller G; Dupont B; O'Reilly R J
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
Blood 1996;87(6):2594-603.
1996: Kernan N A; Dupont B
Minor histocompatibility antigens and marrow transplantation.
The New England journal of medicine 1996;334(5):323-4.
1996: Ng J; Hurley C K; Carter C; Baxter-Lowe L A; Bing D; Chopek M; Hegland J; Lee T D; Li T C; Hsu S; KuKuruga D; Mason J M; Monos D; Noreen H; Rosner G; Schmeckpeper B; Dupont B; Hartzman R J
Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2.
Tissue antigens 1996;47(1):21-6.
1995: Dupont B
"Phototyping" for HLA: the beginning of the end of HLA typing as we know it.
Tissue antigens 1995;46(5):353-4.
1995: August A; Dupont B
Activation of extracellular signal-regulated protein kinase (ERK/MAP kinase) following CD28 cross-linking: activation in cells lacking p56lck.
Tissue antigens 1995;46(3 ( Pt 1)):155-62.
1995: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Mach B; Mayr W R
Nomenclature for factors of the HLA system, 1995.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1995;22(4):335-60.
1995: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Mach B; Mayr W R
Nomenclature for factors of the HLA system, 1995.
Tissue antigens 1995;46(1):1-18.
1995: King P D; Sandberg E T; Selvakumar A; Fang P; Beaudet A L; Dupont B
Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):6080-93.
1995: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Mach B; Mayr W R
Nomenclature for factors of the HLA system, 1995.
Human immunology 1995;43(2):149-64.
1995: Selvakumar A; Granja C B; Salazar M; Alosco S M; Yunis E J; Dupont B
A novel subtype of A2 (A*0217) isolated from the South American Indian B-cell line AMALA.
Tissue antigens 1995;45(5):343-7.
1995: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Mach B; Mayr W R
Nomenclature for factors of the HLA system, 1995.
Vox sanguinis 1995;69(4):359-72.
1994: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1994.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1994;21(6):485-517.
1994: Dupont B
TCC not TTC: the integrity of the HLA nucleotide sequence database.
Tissue antigens 1994;44(4):209-10.
1994: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1994.
Human immunology 1994;41(1):1-20.
1994: August A; Gibson S; Kawakami Y; Kawakami T; Mills G B; Dupont B
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9347-51.
1994: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1994.
Tissue antigens 1994;44(1):1-18.
1994: August A; Dupont B
CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase.
International immunology 1994;6(5):769-74.
1994: August A; Dupont B
Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line.
Biochemical and biophysical research communications 1994;199(3):1466-73.
1994: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1994.
Vox sanguinis 1994;67(4):412-30.
1993: Mickelson E M; Bartsch G E; Hansen J A; Dupont B
The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers.
Tissue antigens 1993;42(5):465-72.
1993: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1991.
Immunobiology 1993;187(1-2):51-69.
1993: Selvakumar A; White P C; Dupont B
Genomic organization of the mouse B-lymphocyte activation antigen B7.
Immunogenetics 1993;38(4):292-5.
1992: Goldbach-Mansky R; King P D; Taylor A P; Dupont B
A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B.
International immunology 1992;4(12):1351-60.
1992: Geisberg M; Terry L A; Flomenberg N; Dupont B
Cytotoxic and proliferative allospecific T-cell clones contain perforin and mediate anti-CD3-induced cytotoxicity.
Human immunology 1992;35(4):239-45.
1992: Geisberg M; Dupont B
Cytolytic effector function is present in resting peripheral T lymphocytes.
International immunology 1992;4(11):1273-81.
1992: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1991.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1992;19(5):327-44.
1992: Young J W; Koulova L; Soergel S A; Clark E A; Steinman R M; Dupont B
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
The Journal of clinical investigation 1992;90(1):229-37.
1992: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1991.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1992;19(3):95-119.
1992: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1991.
Human immunology 1992;34(1):4-18.
1992: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.
Tissue antigens 1992;39(4):161-73.
1992: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1991.
Vox sanguinis 1992;63(2):142-57.
1991: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1990. WHO Committee for Factors of the HLA System.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1991;18(4):265-77.
1991: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1990.
Human immunology 1991;31(3):186-94.
1991: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1990.
Immunobiology 1991;182(3-4):334-45.
1991: Fleischhauer K; Kernan N A; Dupont B; Yang S Y
The two major subtypes of HLA-B44 differ for a single amino acid in codon 156.
Tissue antigens 1991;37(3):133-7.
1991: Koulova L; Clark E A; Shu G; Dupont B
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
The Journal of experimental medicine 1991;173(3):759-62.
1991: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1990.
Tissue antigens 1991;37(3):97-104.
1991: Carabasi M H; DiSanto J P; Yang S Y; Dupont B
Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Tissue antigens 1991;37(1):26-32.
1991: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Dupont B; Erlich H A; Mach B; Mayr W R; Parham P; Sasazuki T
Nomenclature for factors of the HLA system, 1990.
Vox sanguinis 1991;61(2):147-55.
1990: Fleischhauer K; Kernan N A; O'Reilly R J; Dupont B; Yang S Y
Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.
The New England journal of medicine 1990;323(26):1818-22.
1990: Trapani J A; Dupont B
Novel putative promoter/enhancer sequences are shared by the mouse and human perforin (Pfp) genes.
Tissue antigens 1990;36(5):228-34.
1990: Koulova L; Yang S Y; Dupont B
Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(7):2035-43.
1990: Bodmer J G; Marsh S G; Parham P; Erlich H A; Albert E; Bodmer W F; Dupont B; Mach B; Mayr W R; Sasazuki T
Nomenclature for factors of the HLA system, 1989.
Human immunology 1990;28(3):326-42.
1990: Klein J L; Selvakumar A; Trapani J A; Dupont B
Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C).
Tissue antigens 1990;35(5):220-8.
1990: Geisberg M; Trapani J A; Dupont B
Monoclonal antibodies detecting discrete epitopes of human perforin.
Tissue antigens 1990;35(5):229-33.
1990: Rosenkrantz K; Keever C; Bhimani K; Horvath A; Brochstein J; O'Reilly R; Dupont B; Flomenberg N
Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(5):1721-8.
1990: Rosenkrantz K; Bhimani K; Welte K; Buck J; DiSanto J; Levi E; DiMartino J; Hammerling U; Dupont B; Flomenberg N
A novel autoregulatory cytokine is required for the regulation of autoaggressive responses.
Human immunology 1990;27(3):254-64.
1990: Trapani J A; Kwon B S; Kozak C A; Chintamaneni C; Young J D; Dupont B
Genomic organization of the mouse pore-forming protein (perforin) gene and localization to chromosome 10. Similarities to and differences from C9.
The Journal of experimental medicine 1990;171(2):545-57.
1990: Bodmer J G; Marsh S G; Parham P; Erlich H A; Albert E; Bodmer W F; Dupont B; Mach B; Mayr W R; Sasazuki T
Nomenclature for factors of the HLA system, 1989.
Immunobiology 1990;180(2-3):278-92.
1990: Hämmerling G J; Chamberlain J W; Dill O; Yang S Y; Dupont B; Khan R; Chua R; Weissman S M; Hämmerling U
Self-tolerance to HLA focuses the response of immunized HLA-transgenic mice on production of antibody to precise polymorphic HLA alloantigens.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(1):235-9.
1990: Bodmer J G; Marsh S G; Parham P; Erlich H A; Albert E; Bodmer W F; Dupont B; Mach B; Mayr W R; Sasazuki T
Nomenclature for factors of the HLA system, 1989.
Tissue antigens 1990;35(1):1-8.
1989: Bordignon C; Keever C A; Small T N; Flomenberg N; Dupont B; O'Reilly R J; Kernan N A
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms.
Blood 1989;74(6):2237-43.
1989: Kato K; Trapani J A; Allopenna J; Dupont B; Yang S Y
Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(10):3371-8.
1989: Keever C A; Flomenberg N; Small T; Brochstein J; Collins N; Young-Yang S; Insel R; Dupont B; O'Reilly R J
Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease.
Human immunology 1989;26(1):27-38.
1989: Dupont B
Nomenclature for factors of the HLA system, 1987. Decisions of the Nomenclature Committee on Leukocyte Antigens, which met in New York on November 21-23, 1987.
Human immunology 1989;26(1):3-14.
1989: Klein J L; Shows T B; Dupont B; Trapani J A
Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes.
Genomics 1989;5(1):110-7.
1989: Small T N; Keever C; Collins N; Dupont B; O'Reilly R J; Flomenberg N
Characterization of B cells in severe combined immunodeficiency disease.
Human immunology 1989;25(3):181-93.
1989: Frame J N; Collins N H; Cartagena T; Waldmann H; O'Reilly R J; Dupont B; Kernan N A
T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads.
Transplantation 1989;47(6):984-8.
1989: Frame J N; Sheehy D; Cartagena T; Cirrincione C; O'Reilly R J; Dupont B; Kernan N A
Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis.
Bone marrow transplantation 1989;4(1):55-61.
1989: Kato K; Dupont B; Yang S Y
Localization of nucleotide sequence which determines Mongoloid subtype of HLA-B13.
Immunogenetics 1989;29(2):117-20.
1989: Mizuno S; Kang S H; Lee H W; Trapani J A; Dupont B; Yang S Y
Isolation and expression of a cDNA clone encoding HLA-Cw6: unique characteristics of HLA-C encoded gene products.
Immunogenetics 1989;29(5):323-30.
1989: Trapani J A; Mizuno S; Kang S H; Yang S Y; Dupont B
Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody.
Immunogenetics 1989;29(1):25-32.
1988: Yang S Y; Denning S M; Mizuno S; Dupont B; Haynes B F
A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.
The Journal of experimental medicine 1988;168(4):1457-68.
1988: Trapani J A; Klein J L; White P C; Dupont B
Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(18):6924-8.
1988: Keever C A; Flomenberg N; Brochstein J; Sullivan M; Collins N H; Burns J; Dupont B; O'Reilly R J
Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency.
Clinical immunology and immunopathology 1988;48(3):261-76.
1988: Chouaib S; Bensussan A; Termijtelen A M; Andreeff M; Marchiol-Fournigault C; Fradelizi D; Dupont B
Allogeneic T cell activation triggering by MHC class I antigens.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(2):423-9.
1988: Kernan N A; Byers V; Scannon P J; Mischak R P; Brochstein J; Flomenberg N; Dupont B; O'Reilly R J
Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.
JAMA : the journal of the American Medical Association 1988;259(21):3154-7.
1988: White P C; Vitek A; Dupont B; New M I
Characterization of frequent deletions causing steroid 21-hydroxylase deficiency.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4436-40.
1988: Mizuno S; Trapani J A; Koller B H; Dupont B; Yang S Y
Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(11):4024-30.
1988: Yang S Y; Rhee S; Welte K; Dupont B
Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(7):2115-20.
1988: Zemmour J; Ennis P D; Parham P; Dupont B
Comparison of the structure of HLA-Bw47 to HLA-B13 and its relationship to 21-hydroxylase deficiency.
Immunogenetics 1988;27(4):281-7.
1987: Dupont B; Flomenberg N; Yang S Y
Alloantigens stimulating graft-v-host disease.
Transplantation proceedings 1987;19(6 Suppl 7):48-51.
1987: Rosenkrantz K; Keever C; Kirsch J; Horvath A; Bhimani K; O'Reilly R; Dupont B; Flomenberg N
In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.
Transplantation proceedings 1987;19(6 Suppl 7):98-103.
1987: O'Reilly R J; Keever C; Kernan N A; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
Transplantation proceedings 1987;19(6 Suppl 7):55-60.
1987: Chouaib S; Robb R J; Welte K; Dupont B
Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate.
The Journal of clinical investigation 1987;80(2):333-40.
1987: Rosenkrantz K; Dupont B; Williams D; Flomenberg N
Autocytotoxic and autosuppressor T-cell lines generated from autologous lymphocyte cultures.
Human immunology 1987;19(3):189-203.
1987: Kernan N A; Flomenberg N; Dupont B; O'Reilly R J
Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes.
Transplantation 1987;43(6):842-7.
1987: Small T N; Knowles R W; Keever C; Kernan N A; Collins N; O'Reilly R J; Dupont B; Flomenberg N
M241 (CD1) expression on B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(9):2864-8.
1987: Rosenkrantz K; Dupont B; Flomenberg N
Relevance of autocytotoxic and autoregulatory lymphocytes in the maintenance of self tolerance.
Concepts in immunopathology 1987;4():24-41.
1986: Bernard A; Knowles R W; Naito K; Dupont B; Raynal B; Tran H C; Boumsell L
A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functions.
Human immunology 1986;17(4):388-405.
1986: Werkmeister J W; New M I; Dupont B; White P C
Frequent deletion and duplication of the steroid 21-hydroxylase genes.
American journal of human genetics 1986;39(4):461-9.
1986: Knowles R W; Flomenberg N; Horibe K; Winchester R; Radka S F; Dupont B
Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(8):2618-26.
1986: Kernan N A; Collins N H; Juliano L; Cartagena T; Dupont B; O'Reilly R J
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.
Blood 1986;68(3):770-3.
1986: Yang S Y; Chouaib S; Dupont B
A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(4):1097-100.
1986: Horibe K; Knowles R W; Dupont B
A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
Human immunology 1986;16(1):14-23.
1986: White P C; Werkmeister J; New M I; Dupont B
Steroid 21-hydroxylase deficiency and the major histocompatibility complex.
Human immunology 1986;15(4):404-15.
1986: Pistillo M P; Hämmerling U; Dupont B; Ferrara G B
In vitro production of a human HLA alloantibody of restricted specificity (DQw2) via Epstein-Barr virus transformation.
Human immunology 1986;15(1):109-17.
1986: O'Reilly R J; Brochstein J; Collins N; Keever C; Kapoor N; Kirkpatrick D; Kernan N; Dupont B; Burns J; Reisner Y
Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency.
Vox sanguinis 1986;51 Suppl 2():81-6.
1985: Safai B; Johnson K G; Myskowski P L; Koziner B; Yang S Y; Cunningham-Rundles S; Godbold J H; Dupont B
The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome.
Annals of internal medicine 1985;103(5):744-50.
1985: White P C; New M I; Dupont B
Adrenal 21-hydroxylase cytochrome P-450 genes within the MHC class III region.
Immunological reviews 1985;87():123-50.
1985: Kernan N A; Flomenberg N; Collins N H; O'Reilly R J; Dupont B
Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay.
Transplantation 1985;40(3):317-22.
1985: Safai B; Sarngadharan M G; Koziner B; Godbold J; Myskowski P L; Cunningham-Rundles S; Johnson K; Gold J; Krown S; Dupont B
Spectrum of Kaposi's sarcoma in the epidemic of AIDS.
Cancer research 1985;45(9 Suppl):4646s-4648s.
1985: Laster A J; Palker T J; Harden E A; Ho W; Naito K; DuPont B; Haynes B F
Antibody against T lymphoblastic leukemia-associated antigen (3-40) identifies vimentin and keratin intermediate filaments in normal cells.
Blood 1985;66(3):642-8.
1985: Chouaib S; Welte K; Mertelsmann R; Dupont B
Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1172-9.
1985: Speiser P W; Dupont B; Rubinstein P; Piazza A; Kastelan A; New M I
High frequency of nonclassical steroid 21-hydroxylase deficiency.
American journal of human genetics 1985;37(4):650-67.
1985: Pang S; Pollack M S; Loo M; Green O; Nussbaum R; Clayton G; Dupont B; New M I
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism 1985;61(1):89-97.
1985: Rosenkrantz K; Dupont B; Flomenberg N
Generation and regulation of autocytotoxicity in mixed lymphocyte cultures: evidence for active suppression of autocytotoxic cells.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(13):4508-12.
1985: O'Reilly R J; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
The Tokai journal of experimental and clinical medicine 1985;10(2-3):99-107.
1985: Myskowski P L; Pollack M S; Schorr E; Dupont B; Safai B
Human leukocyte antigen associations in basal cell carcinoma.
Journal of the American Academy of Dermatology 1985;12(6):997-1000.
1985: Chouaib S; Welte K; Dupont B
Differential effect of anti-beta 2-microglobulin on IL 2 production and IL 2 receptor expression in the primary mixed lymphocyte culture reaction.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(2):940-8.
1985: White P C; Grossberger D; Onufer B J; Chaplin D D; New M I; Dupont B; Strominger J L
Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(4):1089-93.
1985: O'Reilly R J; Kirkpatrick D; Kapoor N; Collins N; Brochstein J; Kernan N; Flomenberg N; Pollack M; Dupont B; Lopez C
A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.
Progress in clinical and biological research 1985;193():327-42.
1985: White P C; New M I; Dupont B
Molecular cloning of steroid 21-hydroxylase.
Annals of the New York Academy of Sciences 1985;458():277-87.
1985: Pang S; Pollack M S; Loo M; Green O; Nussbaum R; Clayton G; Dupont B; New M I
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
Annals of the New York Academy of Sciences 1985;458():111-29.
1985: Broxmeyer H E; Dupont B
A role for class-II major histocompatibility complex antigens in the regulation of myelopoiesis.
Progress in allergy 1985;36():203-21.
1985: Flomenberg N; Knowles R W; Williams D; Horibe K; Rosenkrantz K; Dupont B
T lymphocyte clones detecting novel supertypic HLA class II allospecificities.
Immunogenetics 1985;22(3):295-300.
1984: Delaney V; Watson A J; Pollack M; Dupont B; Bourke E
HLA typing in bartter syndrome.
American journal of medical genetics 1984;19(4):779-82.
1984: White P C; New M I; Dupont B
HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(23):7505-9.
1984: Horibe K; Flomenberg N; Pollack M S; Adams T E; Dupont B; Knowles R W
Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(6):3195-202.
1984: Pollack M S; Gold J; Metroka C E; Safai B; Dupont B
HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections.
Human immunology 1984;11(2):99-103.
1984: Russo C; Flomenberg N; Dupont B; Ferrone S
Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones.
Cellular immunology 1984;88(1):228-32.
1984: Popovic M; Flomenberg N; Volkman D J; Mann D; Fauci A S; Dupont B; Gallo R C
Alteration of T-cell functions by infection with HTLV-I or HTLV-II.
Science (New York, N.Y.) 1984;226(4673):459-62.
1984: Kernan N A; Knowles R W; Burns M J; Broxmeyer H E; Lu L; Lee H M; Kawahata R T; Scannon P J; Dupont B
Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(1):137-46.
1984: de Jongh B M; Veldhuis J D; Drop S L; Nijenhuis L E; Dupont B
Linkage and segregation analysis of HLA and congenital hypoaldosteronism due to corticosterone methyl-oxydase deficiency type I and type II.
Tissue antigens 1984;24(1):18-24.
1984: Broxmeyer H E; Juliano L; Lu L; Platzer E; Dupont B
HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
The Journal of clinical investigation 1984;73(4):939-53.
1984: Flomenberg N; Duffy E; Dupont B
HLA class-II-specific T-lymphocyte clones with dual alloreactive functions.
Scandinavian journal of immunology 1984;19(3):237-45.
1984: White P C; Dupont B; New M I
Molecular cloning of steroid 21-hydroxylase.
Endocrine research 1984;10(3-4):335-45.
1984: Flomenberg N; Russo C; Ferrone S; Dupont B
HLA class I specific T lymphocyte clones with dual alloreactive functions.
Immunogenetics 1984;19(1):39-51.
1984: Yang S Y; Morishima Y; Collins N H; Alton T; Pollack M S; Yunis E J; Dupont B
Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes.
Immunogenetics 1984;19(3):217-31.
1983: Flomenberg N; Dupont B; O'Reilly R J; Hayward A; Pollack M S
The use of T cell culture techniques to establish the presence of an intrauterine-derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID).
Transplantation 1983;36(6):733-5.
1983: Petit A; Dupont B; Sansonetti P; Raffoux C; Lapresle C
[Horton's disease. Study of HLA group. Apropos of 3 familial cases]
Presse médicale (Paris, France : 1983) 1983;12(40):2536.
1983: Flomenberg N; Naito K; Duffy E; Knowles R W; Evans R L; Dupont B
Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens.
European journal of immunology 1983;13(11):905-11.
1983: Naito K; Knowles R W; Real F X; Morishima Y; Kawashima K; Dupont B
Analysis of two new leukemia-associated antigens detected on human T-cell acute lymphoblastic leukemia using monoclonal antibodies.
Blood 1983;62(4):852-65.
1983: Pollack M S; Chin-Louie J; Callaway C; Blanco M A; Slavin K; Sullivan K; O'Reilly R J; Dupont B
Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
Journal of clinical immunology 1983;3(4):341-51.
1983: New M I; Lorenzen F; Lerner A J; Kohn B; Oberfield S E; Pollack M S; Dupont B; Stoner E; Levy D J; Pang S; Levine L S
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.
The Journal of clinical endocrinology and metabolism 1983;57(2):320-6.
1983: Flomenberg N; Welte K; Mertelsmann R; Kernan N; Ciobanu N; Venuta S; Feldman S; Kruger G; Kirkpatrick D; Dupont B; O'Reilly R
Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(6):2644-50.
1983: Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(6):2635-43.
1983: Safai B; Myskowski P L; Dupont B; Pollack M S
Association of HLA-DR5 with mycosis fungoides.
The Journal of investigative dermatology 1983;80(5):395-7.
1983: Mandel F P; Chang R J; Dupont B; Pollack M S; Levine L S; New M I; Lu J K; Judd H L
HLA genotyping in family members and patients with familial polycystic ovarian disease.
The Journal of clinical endocrinology and metabolism 1983;56(4):862-4.
1983: Pollack M S; da Silva B M; Moshief R D; Groshen S; Bognacki J; Dupont B; de Sousa M
Ferritin secretion by human mononuclear cells: association with HLA phenotype.
Clinical immunology and immunopathology 1983;27(1):124-34.
1983: Reisner Y; Kapoor N; Kirkpatrick D; Pollack M S; Cunningham-Rundles S; Dupont B; Hodes M Z; Good R A; O'Reilly R J
Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.
Blood 1983;61(2):341-8.
1983: Pollack M S; Safai B; Myskowski P L; Gold J W; Pandey J; Dupont B
Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
Tissue antigens 1983;21(1):1-8.
1983: Pollack M S; Callaway C; LeBlanc D; Robinson H M; Mastrota F; Dupont B; Koziner B
Lymphocytotoxic antibodies to non-HLA antigens in the sera of patients with acquired immunodeficiency syndrome (AIDS).
Progress in clinical and biological research 1983;133():209-13.
1983: O'Reilly R J; Kapoor N; Kirkpatrick D; Flomenberg N; Pollack M S; Dupont B; Good R A; Reisner Y
Transplantation of hematopoietic cells for lethal congenital immunodeficiencies.
Birth defects original article series 1983;19(3):129-37.
1982: Kornbluth J; Flomenberg N; Dupont B
Cell surface phenotype of a cloned line of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(6):2831-7.
1982: O'Neill G J; Miniter P; Nerl C; Yang S Y; Dupont B; Pollack M S
The BF locus and HLA: rare alleles coding for functionally active and inactive factor-B products.
Human immunology 1982;5(3):239-46.
1982: Kohn B; Levine L S; Pollack M S; Pang S; Lorenzen F; Levy D; Lerner A J; Rondanini G F; Dupont B; New M I
Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism 1982;55(5):817-27.
1982: Pollack M S; Kirkpatrick D; Kapoor N; Dupont B; O'Reilly R J
Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.
The New England journal of medicine 1982;307(11):662-6.
1982: Morishima Y; Kobayashi M; Yang S Y; Collins N H; Hoffmann M K; Dupont B
Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1091-8.
1982: Chan K W; Pollack M S; Braun D; O'Reilly R J; Dupont B
Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation.
Transplantation 1982;33(6):613-5.
1982: Pollack M S; Vugrin D; Hennessy W; Herr H W; Dupont B; Whitmore W F
HLA antigens in patients with germ cell cancers of the testis.
Cancer research 1982;42(6):2470-3.
1982: O'Neill G J; Dupont B; Pollack M S; Levine L S; New M I
Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus.
Clinical immunology and immunopathology 1982;23(2):312-22.
1982: Pollack M S; Wysocki C J; Beauchamp G K; Braun D; Callaway C; Dupont B
Absence of HLA association or linkage for variations in sensitivity to the odor of androstenone.
Immunogenetics 1982;15(6):579-89.
1982: Morishima Y; Ogata S; Collins N H; Dupont B; Lloyd K O
Carbohydrate differences in human high molecular weight antigens of B- and T-cell lines.
Immunogenetics 1982;15(5):529-35.
1981: Korein J; Willoughby E; Pollack M S; Levidow L; Dupont B
Human leukocyte anitgen in torticollis and other idiopathic dystonic syndromes.
Annals of neurology 1981;10(6):573-5.
1981: Levine L S; Dupont B; Lorenzen F; Pang S; Pollack M; Oberfield S E; Kohn B; Lerner A; Cacciari E; Mantero F; Cassio A; Scaroni C; Chiumello G; Rondanini G F; Gargantini L; Giovannelli G; Virdis R; Bartolotta E; Migliori C; Pintor C; Tato L; Barboni F; New M I
Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.
The Journal of clinical endocrinology and metabolism 1981;53(6):1193-8.
1981: Górski A; Gaciong Z; Dupont B
Enhanced clonability of human T lymphocytes caused by their culturing in vitro.
Immunology 1981;44(3):617-22.
1981: Miniter P; Chan K W; Pollack M S; Dupont B; O'Neill G J
HLA-linked genetic markers in Chinese and other Oriental populations.
Tissue antigens 1981;18(5):285-98.
1981: Reisner Y; Kapoor N; Kirkpatrick D; Pollack M S; Dupont B; Good R A; O'Reilly R J
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.
Lancet 1981;2(8242):327-31.
1981: Pollack M S; Levine L S; O'Neill G J; Pang S; Lorenzen F; Kohn B; Rondanini G F; Chiumello G; New M I; Dupont B
HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency.
American journal of human genetics 1981;33(4):540-50.
1981: Sorell M; Kapoor N; Kirkpatrick D; Rosen J F; Chaganti R S; Lopez C; Dupont B; Pollack M S; Terrin B N; Harris M B; Vine D; Rose J S; Goossen C; Lane J; Good R A; O'Reilly R J
Marrow transplantation for juvenile osteopetrosis.
The American journal of medicine 1981;70(6):1280-7.
1981: Antonelli P; Stewart W; Dupont B
Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation.
Clinical immunology and immunopathology 1981;19(2):161-9.
1981: Christiansen F T; Kim S J; Gosar I; Silver D M; Pollack M S; Dupont B
Alloantibodies reacting exclusively with PHA-activated T lymphocytes.
Transplantation proceedings 1981;13(1 Pt 2):1189-92.
1981: Kornbluth J; Dupont B
Characterization of primary alloreactive clones of human T lymphocytes.
Transplantation proceedings 1981;13(1 Pt 2):1138-42.
1981: Pollack M S; Kapoor N; Sorell M; Morishima Y; Dupont B; O'Reilly R J
Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells.
Transplantation proceedings 1981;13(1 Pt 1):270-2.
1981: Kim S J; Christiansen F; Silver D M; Dupont B
Target determinants in CML identified by cytotoxic effector cells generated against HLA antigens in strong genetic linkage disequilibrium.
Transplantation proceedings 1981;13(1 Pt 2):982-7.
1981: Christiansen F T; Kim S J; Silver D M; Dupont B
Cytotoxic effector cells against HLA antigens in strong linkage disequilibrium: identification of a strong, new CML determinant.
Human immunology 1981;2(1):15-29.
1981: Brautbar C; Theodor R; Sack J; Levene C; Dupont B; Levine L S; Sharon R; Smaller S; Cohen T; Rösler A
HLA in a selective aldosterone biosynthetic defect due to type 2 corticosterone methyl-oxidase deficiency.
Tissue antigens 1981;17(2):212-6.
1981: Dupont B; Flomenberg N; O'Reilly R J
Bone marrow transplantation for correction of severe aplastic anemia and primary immunodeficiency.
Annals of clinical research 1981;13(4-5):358-66.
1981: New M I; Dupont B; Pang S; Pollack M; Levine L S
An update of congenital adrenal hyperplasia.
Recent progress in hormone research 1981;37():105-81.
1981: Pollack M S; New M I; O'Neill G J; Levine L S; Callaway C; Pang S; Cacciari E; Mantero F; Cassio A; Scaroni C; Chiumello G; Rondanini G F; Gargantini L; Giovannelli G; Virdis R; Bartolotta E; Migliori C; Pintor C; Tato L; Barboni F; Dupont B
HLA genotypes and HLA-linked genetic markers in Italian patients with classical 21-hydroxylase deficiency.
Human genetics 1981;58(3):331-7.
1981: Yang S Y; Coleman P; Ochs H D; Dupont B
Inheritance and genetic linkage of transcobalamin II.
Human genetics 1981;57(3):307-11.
1981: Bryan C F; Nishiya K; Pollack M S; Dupont B; de Sousa M
Differential inhibition of the MLR by iron: association with HLA phenotype.
Immunogenetics 1981;12(1-2):129-40.
1981: New M I; Dupont B; Pollack M S; Levine L S
The biochemical basis for genotyping 21-hydroxylase deficiency.
Human genetics 1981;58(1):123-7.
1981: Kim S J; Christiansen F T; Silver D M; Dupont B
Differential behavior of cytotoxic effector cells against HLA antigens in strong genetic linkage disequilibrium.
Immunogenetics 1981;13(4):297-309.
1981: Kornbluth J; Silver D M; Dupont B
Cloning and characterization of primary alloreactive human T-lymphocytes.
Immunological reviews 1981;54():111-55.
1980: Kim S J; Christiansen F T; Gosar I; Silver D M; Pollack M S; Dupont B
Frequency of alloantibodies reacting with PHA-activated T lymphocytes, unexplainable by known HLA activities.
Human immunology 1980;1(4):347-55.
1980: Levine L S; Dupont B; Lorenzen F; Pang S; Pollack M; Oberfield S; Kohn B; Lerner A; Cacciari E; Mantero F; Cassio A; Scaroni C; Chiumello G; Rondanini G F; Gargantini L; Giovannelli G; Virdis R; Bartolotta E; Migliori C; Pintor C; Tato L; Barboni F; New M I
Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism 1980;51(6):1316-24.
1980: Pollack M S; Kapoor N; Sorell M; Kim S J; Christiansen F T; Silver D M; Dupont B; O'Reilly R J
DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease.
Transplantation 1980;30(5):331-4.
1980: Pollack M S; Schafer I A; Barford D; Dupont B
Prenatal identification of paternity. HLA typing helpful after rape.
JAMA : the journal of the American Medical Association 1980;244(17):1954-6.
1980: Pollack M S; Ochs H D; Dupont B
HLA typing of cultured amniotic cells for the prenatal diagnosis of complement C4 deficiency.
Clinical genetics 1980;18(3):197-200.
1980: Kornbluth J; Dupont B
Cloning and functional characterization of primary alloreactive human T lymphocytes.
The Journal of experimental medicine 1980;152(2 Pt 2):164s-181s.
1980: Pollack M S; Zaroulis C G; Klainbard J; Leiderman I Z; Dupont B
Retention of HLA antigens on previously frozen human platelets.
Transfusion 1980;20(4):458-61.
1980: O'Neill G J; Miniter P; Pollack M S; Dupont B
Different HLA antigen associations for the functionally active and inactive products of the complement C4F1 allele.
Human immunology 1980;1(1):23-30.
1980: DeWolf W C; Dupont B; Yunis E J
HLA and disease: current concepts.
Human pathology 1980;11(4):332-37.
1980: Laron Z; Pollack M S; Zamir R; Roitman A; Dickerman Z; Levine L S; Lorenzen F; O'Neill G J; Pang S; New M I; Dupont B
Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus.
Human immunology 1980;1(1):55-66.
1980: Dinsmore R E; Straus D J; Pollack M S; Woodruff J M; Garrett T J; Young C W; Clarkson B D; Dupont B
Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.
Blood 1980;55(5):831-4.
1980: Cunningham-Rundles S; Cunningham-Rundles C; Dupont B; Good R A
Zinc-induced activation of human B lymphocytes.
Clinical immunology and immunopathology 1980;16(1):115-22.
1980: Willoughby E; Price R W; Padgett B L; Walker D L; Dupont B
Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus.
Neurology 1980;30(3):256-62.
1980: Pollack M S; Livingston P O; Fogh J; Carey T E; Oettgen H F; Dupont B
Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines.
Tissue antigens 1980;15(3):249-56.
1980: Pang S; Levine L S; Lorenzen F; Chow D; Pollack M; Dupont B; Genel M; New M I
Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism 1980;50(3):586-9.
1980: Lorenzen F; Pang S; New M; Pollack M; Oberfield S; Dupont B; Chow D; Schneider B; Levine L
Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
The Journal of clinical endocrinology and metabolism 1980;50(3):572-7.
1980: Levine L S; Pang S; Dupont B; Pollack M; Lorenzen F; New M I
Detection of heterozygote of 21-hydroxylase deficiency.
Lancet 1980;1(8168 Pt 1):603-4.
1980: New M I; Oberfield S E; Levine L S; Dupont B; Pollack M; Gill J R; Bartter F C
Autosomal dominant transmission and absence of HLA linkage in dexamethasone suppressible hyperaldosteronism.
Lancet 1980;1(8167):550-1.
1980: Dupont B; O'Reilly R J; Pollack M S; Good R A
Histocompatibility testing for clinical bone marrow transplantation and prospects for identification of donors other than HLA genotypically identical siblings.
Haematology and blood transfusion 1980;25():121-34.
1980: O'Neill G J; Dupont B
The genetic control of the fourth component of human complement C4.
Immunobiology 1980;158(1-2):42-4.
1979: Ballow M; McLean R H; Einarson M; Martin S; Yunis E J; Dupont B; O'Neill G J
Hereditary C4 deficiency--genetic studies and linkage to HLA.
Transplantation proceedings 1979;11(4):1710-2.
1979: Cunningham-Rundles S; Brown A; Gross D; Braun D; Hansen J A; Good R A; Armstrong D; Dupont B
Association of HLA in immune response to influenza-A immunization.
Transplantation proceedings 1979;11(4):1849-52.
1979: Pollack M S; Maurer D; Levine L S; New M I; Pang S; Duchon M A; Owens R P; Merkatz I R; Nitowsky H M; Sachs G; Dupont B
HLA typing of amniotic cells: the prenatal diagnosis of congenital adrenal hyperplasia (21-OH-deficiency type).
Transplantation proceedings 1979;11(4):1726-8.
1979: O'Neill G J; Pollack M S; Yang S Y; Levine L S; New M I; Dupont B
Gene frequencies and genetic linkage disequilibrium for the HLA-linked genes Bf, C2, C4S, C4F, 21-hydroxylase deficiency, and glyoxalase I.
Transplantation proceedings 1979;11(4):1713-5.
1979: Lorenzen F; Pang S; New M I; Dupont B; Pollack M; Chow D M; Levine L S
Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency).
Pediatric research 1979;13(12):1356-60.
1979: Kornbluth J; Gorski A; Dupont B
Alloantigen-activated lymphocyte colony formation in semisolid agar.
Transplantation proceedings 1979;11(4):1978-81.
1979: O'Neill G J; Berger R; Ballow M; Yunis E J; Dupont B
Chido, Rodgers, and C4 deficiency.
Transplantation proceedings 1979;11(4):1941-3.
1979: O'Reilly R J; Kapoor N; Pollack M; Sorell M; Chaganti R S; Blaese R M; Wank R; Good R A; Dupont B
Reconstitution of immunologic function in a patient with severe combined immunodeficiency following transplantation of marrow from an HLA-A,B,C nonidentical but MLC-compatible paternal donor.
Transplantation proceedings 1979;11(4):1934-7.
1979: Bean M A; Akiyama M; Kodera Y; Dupont B; Hansen J A
Human blood T lymphocytes that suppress the mixed leukocyte culture reactivity of lymphocytes from HLA-B14 bearing individuals.
Journal of immunology (Baltimore, Md. : 1950) 1979;123(4):1610-4.
1979: Levine L S; New M I; Pollack M; Dupont B
Prenatal diagnosis of congenital adrenal hyperplasia.
Lancet 1979;2(8143):637.
1979: Pollack M S; Yang S Y; O'Neill G J; O'Reilly R J; Grossbard E; Kapoor N; Good R A; Dupont B
Bone marrow transplantation using typing for glyoxalase I as a tool in histocompatibility testing.
Transplantation 1979;28(2):156-8.
1979: Duquesnoy R J; Marrari M; Annen K; Pollack M S; Dupont B
HLA-DR antigens in Black North-Americans and their association with HLA-D.
Tissue antigens 1979;14(2):145-56.
1979: Pollack M S; Levine L; Zachmann M; Prader A; New M; Oberfield S; Dupont B
Possible genetic linkage disequilibrium between HLA and the 21-hydroxylase deficiency gene (congenital adrenal hyperplasia).
Transplantation proceedings 1979;11(2):1315-6.
1979: Seldin M F; Rich R R; Dupont B
Human immune responses to hapten-conjugated cells. II. The roles of autologous and allogeneic histocompatibility determinants in proliferative responses in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1979;122(5):1828-33.
1979: Pollack M S; Maurer D; Levine L S; New M I; Pang S; Duchon M; Owens R P; Merkatz I R; Nitowsky B M; Sachs G; Dupont B
Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing.
Lancet 1979;1(8126):1107-8.
1979: Dupont B; O'Reilly R J; Pollack M S; Good R A
Use of HLA genotypically different donors in bone marrow transplantation.
Transplantation proceedings 1979;11(1):219-24.
1979: Schendel D J; Wank R; Dupont B
Standardization of the human in vitro cell-mediated lympholysis technique.
Tissue antigens 1979;13(2):112-20.
1979: Brautbar C; Rösler A; Landau H; Cohen I; Nelken D; Cohen T; Levine C; Sack J; Benderli A; Moses S; Lieberman E; Dupont B; Levine L S; New M I
No linkage between HLA and congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency.
The New England journal of medicine 1979;300(4):205-6.
1979: Temple H; Dupont B; Shopsin B
HLA antigen and affective disorders: a report and critical assessment of histocompatibility studies.
Neuropsychobiology 1979;5(1):50-8.
1979: Wank R; Schendel D J; Blanco M E; Dupont B
Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
Scandinavian journal of immunology 1979;9(6):499-505.
1978: Cunningham-Rundles S; Cunningham-Rundles C; Pollack M S; Good R A; Dupont B
Response to wheat antigen in in vitro lymphocyte transformation among HLA-B8-positive normal donors.
Transplantation proceedings 1978;10(4):977-9.
1978: Yang S Y; Levine L S; Zachmann M; New M I; Prader A; Oberfield S E; O'Neill G J; Pollack M S; Dupont B
Mapping of the 21-hydroxylase deficiency gene within the HLA linkage group.
Transplantation proceedings 1978;10(4):753-5.
1978: O'Neill G J; Yang S Y; Dupont B
Chido and Rodgers blood groups: relationship to C4 and HLA.
Transplantation proceedings 1978;10(4):749-51.
1978: Kornbluth J; Pollack M S; Fogh J; Carey T; Dupont B
HLA typing of human tumor cell lines: selection of appropriate typing techniques.
Transplantation proceedings 1978;10(4):735-8.
1978: Schendel D J; Bonnard G D; Wank R; Dupont B
Proliferative and cytotoxic capacities of human cultured T cells.
Transplantation proceedings 1978;10(4):933-5.
1978: Bryan C F; Broxmeyer H E; Hansen J; Pollack M; Dupont B
Identification of an MLC suppressor cell population in acute leukemia.
Transplantation proceedings 1978;10(4):915-8.
1978: Antonelli P; Kamoun M; Hansen J A; Dupont B
Cross-reactivity of anti-DRw sera evaluated by serologic studies on established B-lymphoid cell lines.
Transplantation proceedings 1978;10(4):849-51.
1978: Wank R; Schendel D J; Dupont B
Typing for homozygous determinants with lymphocytes primed to two-haplotype differences.
Transplantation proceedings 1978;10(4):763-6.
1978: O'Reilly R J; Pahwa R; Kirkpatrick D; Sorell M; Kapadia A; Kapoor N; Hansen J A; Pollack M; Schutzer S E; Good R A; Dupont B
Successful transplantation of marrow from an HLA-A, -B, -D mismatched heterozygous sibling donor into an HLA-D-homozygous patient with aplastic anemia.
Transplantation proceedings 1978;10(4):957-62.
1978: Levine L S; Zachmann M; New M I; Prader A; Pollack M S; O'Neill G J; Yang S Y; Oberfield S E; Dupont B
Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group.
The New England journal of medicine 1978;299(17):911-5.
1978: O'Neill G J; Yang S Y; Dupont B
Two HLA-linked loci controlling the fourth component of human complement.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(10):5165-9.
1978: Schendel D J; Wank R; Dupont B
Cell-mediated lympholysis: examination of HLA genetic fine structure and complementation using cytotoxic lymphocytes.
European journal of immunology 1978;8(9):634-40.
1978: Niese D; Grosse-Wilde H; Dupont B; Du Toit E; Johannsen R; Suciu-Foca N; Stroehmann I; Rittner C
Evidence for subtypic determinants in the HLA-DW3 cluster.
Human genetics 1978;43(1):23-30.
1978: Gibofsky A; Winchester R; Hansen J; Patarroyo M; Dupont B; Paget S; Lahita R; Halper J; Fotino M; Yunis E; Kunkel H G
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus.
Arthritis and rheumatism 1978;21(5 Suppl):S134-8.
1978: O'Neill G J; Yang S Y; Tegoli J; Berger R; Dupont B
Chido and Rodgers blood groups are distinct antigenic components of human complement C4.
Nature 1978;273(5664):668-70.
1978: O'Reilly R J; Pahwa R; Dupont B; Good R A
Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling.
Transplantation proceedings 1978;10(1):187-99.
1978: Dupont B; Hansen J A
Donor selection for bone marrow transplantation: the predictive value of HLA-D typing for MLR compatibility between unrelated individuals.
Transplantation proceedings 1978;10(1):53-6.
1978: Williams R M; Martin S; Falchuk K R; Trey C; Dubey D P; Cannady W G; Fitzpatrick D; Noreen H; Dupont B; Yunis E J
Increased frequency of HLA-DRW4 in chronic active hepatitis.
Vox sanguinis 1978;35(6):366-9.
1977: Dupont B; Hansen J A; Braun D W; Reinsmoen N; Yunis E Y
Nonrandom selection of HLA-B/D recombinant gametes.
Transplantation proceedings 1977;9(4):1853-4.
1977: Schendel D J; Wank R; Hansen J A; Dupont B
Cell-mediated lympholysis in man: identification of a common target determinant associated with HLA-B12 and Bw35.
Transplantation proceedings 1977;9(4):1777-80.
1977: Wank R; Schendel D J; Hansen J A; Yunis E J; Dupont B
Two different HLA restimulating determinants separated by recombination and titration.
Transplantation proceedings 1977;9(4):1771-5.
1977: Reinsmoen N; Hansen J; Dupont B; Gatti R; Yunis E
Antigenic complexity of the HLA-D region as defined by homozygous typing cells and primed lymphocyte tests.
Transplantation proceedings 1977;9(4):1767-9.
1977: Hansen J A; Lee T D; Whitsett C F; Dupont B
Specific blocking of MLR-stimulating determinants (HLA-D) with B-cell alloantisera: preabsorption of antibody on stimulator cells.
Transplantation proceedings 1977;9(4):1721-6.
1977: Dupont B; Oberfield S E; Smithwick E M; Lee T D; Levine L S
Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency).
Lancet 1977;2(8052-8053):1309-12.
1977: O'Reilly R J; Dupont B; Pahwa S; Grimes E; Smithwick E M; Pahwa R; Schwartz S; Hansen J A; Siegal F P; Sorell M; Svejgaard A; Jersild C; Thomsen M; Platz P; L'Esperance P; Good R A
Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.
The New England journal of medicine 1977;297(24):1311-8.
1977: Case D C; Hansen J A; Corrales E; Young C W; Dupont B; Pinsky C M; Good R A
Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions.
Blood 1977;49(5):771-8.
1977: Hansen J A; Good R A; Dupont B
HLA-D compatibility between parent and child: increased occurrence in severe combined immunodeficiency and other hematopoietic diseases.
Transplantation 1977;23(4):366-74.
1977: Cunningham-Rundles C; Tegoli J; Dupont B; Whitsett C; Good R A
Chemical studies on the Chido antigen.
Transplantation proceedings 1977;9(1):647-51.
1977: Dupont B; Svejgaard A
HLA and disease.
Transplantation proceedings 1977;9(1):1271-4.
1977: Thompson J S; Braun W E; Carpenter C B; Dossetor J B; Dupont B; Falk J A; Ferrone S; Johnson A H; Shaw J F; Sinal D P; Terasaki P I; Troup G M; Walford R L
Report on the second new world B-cell workshop.
Transplantation proceedings 1977;9(1 Suppl 1):9-12.
1977: Cunningham-Rundles C; Dupont B; Jersild C; Tegoli J; Whitsett C; Good R A
Are HLA and Chido related antigenic groups?
Transplantation proceedings 1977;9(1 Suppl 1):33-7.
1977: Górski A J; Dupont B; Hansen J A
Genetic control of mediator production in human MLC.
Transplantation proceedings 1977;9(1 Suppl 1):115-7.
1977: Gorski A J; Dupont B; Hansen J A; Safai B; Pahwa S; Good R A
Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
Journal of immunology (Baltimore, Md. : 1950) 1977;118(3):858-62.
1977: Ochs H D; Rosenfeld S I; Thomas E D; Giblett E R; Alper C A; Dupont B; Schaller J G; Gilliland B C; Hansen J A; Wedgwood R J
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex.
The New England journal of medicine 1977;296(9):470-5.
1977: Whitsett C; Lee T D; Duquesnoy R; Noreen H; Hansen J A; Annen K; Reinsmoen N; Long M A; Yunis E J; Dupont B
B-lymphocyte alloantigens and HLA-D determinants in a North American white population.
Transplantation proceedings 1977;9(1):425-9.
1977: Dupont B; Hansen J A; Whitsett C; Slater L; Lee T D
Population genetics for five HLA-D determinants in caucasians (New York City).
Transplantation proceedings 1977;9(1 Suppl 1):67-72.
1977: Cunningham-Rundles C; Dupont B; Jersild C; Good R A
The tyrosine peptides of HLA and beta2-microglobulin.
Transplantation proceedings 1977;9(1 Suppl 1):29-32.
1977: Dupont B; Lisak R P; Jersild C; Hansen J A; Silberberg D H; Whitsett C; Zweiman B; Ciongoli K
HLA antigens in black American patients with multiple sclerosis.
Transplantation proceedings 1977;9(1 Suppl 1):181-5.
1977: Sousa M D; Yang M; Lopes-Corrales E; Tan C; Hansen J A; Dupont B; Good R A
Ecotaxis: the principle and its application to the study of Hodgkin's disease.
Clinical and experimental immunology 1977;27(1):143-51.
1977: Gallie B L; Dupont B; Whitsett C; Kitchen F D; Ellsworth R M; Good R A
Histocompatibility typing in spontaneous regression of retinoblastoma.
Progress in clinical and biological research 1977;16():229-37.
1977: Hansen G S; Dupont B; Faber V; Jakobsen B K; Juhl F; Nielsen L S; Svejgaard A; Thomsen M; Wiik A
Lymphocyte chimerism after bone marrow transplantation. Surface markers and in vitro function of donor and recipient lymphocyte subpopulations.
Scandinavian journal of immunology 1977;6(4):299-303.
1977: Cunningham-Rundles S; Dupont B; Posner J B; Hansen J A; Good R A
In vitro lymphocyte transformation of MS patients to paramyxovirus antigens.
Acta neurologica Scandinavica. Supplementum 1977;63():145-56.
1977: Hansen J A; Young C W; Whitsett C; Case D C; Jersild C; Good R A; Dupont B
HLA and MLC typing in patients with Hodgkin's disease.
Progress in clinical and biological research 1977;16():217-27.
1976: Whitsett C; Turner W J; Lee T D; Dupont B
HLA antigen frequencies in paralytic dementia.
Journal of the neurological sciences 1976;30(2-3):417-20.
1976: Górski A J; Dupont B; Hansen J A; O'Reilly R; Smithwick E; Górska R; Good R A
Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
Clinical and experimental immunology 1976;26(3):505-10.
1976: Hansen J A; O'Reilly R J; Good R A; Dupont B
Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.
Transplantation proceedings 1976;8(4):581-9.
1976: Thompson J S; Braun W E; Carpenter C B; Dossetor J B; Dupont B; Falk J A; Ferrone S; Johnson A H; Shaw J F; Singal D P; Terasaki T I; Troup G M; Walford R L
Summary report on the second New World B-cell workshop.
Tissue antigens 1976;8(5):355-7.
1976: Case D C; Hansen J A; Corrales E; Young C W; Dupont B; Pinsky C M; Good R A
Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
Cancer 1976;38(4):1807-15.
1976: Jewett M A; Gupta S; Hansen J A; Cunningham-Rundles S; Siegal F P; Good R A; Dupont B
The use of cryopreserved lymphocytes for longitudinal studies of immune function and enumeration of subpopulations.
Clinical and experimental immunology 1976;25(3):449-54.
1976: Górski A J; Dupont B; Hansen J A; Good R A
Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.
Journal of immunology (Baltimore, Md. : 1950) 1976;117(3):865-70.
1976: Cunningham-Rundles S; Feller W F; Cunningham-Rundles C; Dupont B; Wanebo H; O'Reilly R; Good R A
Lymphocyte transformation in vitro to RII mouse milk antigen among woman with breast disease.
Cellular immunology 1976;25(2):322-7.
1976: O'Reilly R J; Everson L K; Emödi G; Hansen J; Smithwick E M; Grimes E; Pahwa S; Pahwa R; Schwartz S; Armstrong D; Siegal F P; Gupta S; Dupont B; Good R A
Effects of exogenous interferon in cytomegalovirus infections complicating bone marrow transplantation.
Clinical immunology and immunopathology 1976;6(1):51-61.
1976: Braunstein J D; Melamed M R; Sharpless T K; Hansen J A; Dupont B; Good R A
Quantitation of lymphocyte proliferative response to allogeneic cells and phytohemagglutinin by flow cytofluorometry. II. Comparison with [14C]thymidine incorporation.
Clinical immunology and immunopathology 1976;5(3):326-32.
1976: Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli A K; Fog T; Grob P
Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
Scandinavian journal of immunology 1976;5(1-2):141-8.
1976: Yunis E J; Dupont B; Hansen J
Immunogenetic aspects of allotransplantation.
Advances in experimental medicine and biology 1976;73 Pt B():231-51.
1976: Day N K; Rubinstein P; Case D; Hansen J A; Good R A; Walker M E; Tulchin N; Dupont B; Jersild C
Linkage of gene for C2 deficiency and the major histocompatibility complex MHC in man. Family study of a further case.
Vox sanguinis 1976;31(2):96-102.
1976: DuPont B; Hansen J A
Human mixed-lymphocyte culture reaction: genetics, specificity, and biological implications.
Advances in immunology 1976;23():107-202.
1975: Cunningham-Rundles C; Jersild C; Svejgaard A; Dupont B; Good R A
Evidence for tryosine peptide homologies in the HLA antigens system.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(12):5081-5.
1975: Cunningham-Rundles S; Dupont B; Posner J B; Hansen J A; Good R A
Letter: Lymphocyte transformation in vitro to paramyxovirus antigens in multiple sclerosis.
Lancet 1975;2(7946):1204.
1975: Dupont B; Hansen J A; Good R A
Letter: Atypical mixed lymphocyte culture identity between mother and child in leukemia and aplastic anemia.
Transplantation 1975;20(3):255-6.
1975: Górski A J; Dupont B; Hansen J A; Good R A
Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(8):3197-200.
1975: Fu S M; Stern R; Kunkel H G; Dupont B; Hansen J A; Day N K; Good R A; Jersild C; Fotino M
Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families.
The Journal of experimental medicine 1975;142(2):495-506.
1975: Day N K; L'Esperance R; Good R A; Michael A F; Hansen J A; Dupont B; Jersild C
Hereditary C2 deficiency: Genetic studies and association with the HL-A system.
The Journal of experimental medicine 1975;141(6):1464-9.
1975: Jersild C; Dupont B; Svejgaard A; Platz P J; Ciongoli K A; Fog T
Proceedings: Genetic factors in multiple sclerosis: the major histocompatibility system (HL-A) and immunity.
Neurology 1975;25(5):488-9.
1975: Winchester R J; Wernet P; Kunkel H G; Dupont B; Jersild C; Fu S M
Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.
The Journal of experimental medicine 1975;141(4):924-9.
1975: Ballow M; Dupont B; Hansen J A; Good R A
Transfer factor therapy: evidence for nonspecificity.
Birth defects original article series 1975;11(1):457-61.
1975: Dupont B; Good R A
Lymphocyte transformation in vitro in patients with immunodeficiency diseases: use in diagnosis, histocompatibility testing and monitoring treatment.
Birth defects original article series 1975;11(1):477-85.
1975: Jersild C; Dupont B; Fog T; Platz P J; Svejgaard A
Histocompatibility determinants in multiple sclerosis.
Transplantation reviews 1975;22():148-63.
1974: Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C
Mixed lymphocyte culture determinants, measles infection and multiple sclerosis.
Proceedings of the Royal Society of Medicine 1974;67(11):1133-6.
1974: Ballow M; Park B H; Dupont B; Caldwell R R; Lonsdale D; Good R A
Benign giant lymphoid hyperplasia of the mediastinum with associated abnormalities of the immune system.
The Journal of pediatrics 1974;84(3):418-20.
1974: Dupont B; Ballow M; Hansen J A; Quick C; Yunis E J; Good R A
Effect of transfer factor therapy on mixed lymphocyte culture reactivity.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(3):867-71.
1974: Dupont B; Good R A; Hansen G S; Jersild C; Nielsen L S; Park B H; Svejgaard A; Thomsen M; Yunis E J
Two separate genes controlling stimulation in mixed lymphocyte reaction in man.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(1):52-6.
1973: Jersild C; Dupont B; Fog T; Hansen G S; Nielsen L S; Thomsen M; Svejgaard A
Histocompatibility-linked immune-response determinants in multiple sclerosis.
Transplantation proceedings 1973;5(4):1791-6.
1973: Dupont B; Jersild C; Hansen G S; Nielsen L S; Thomsen M; Svejgaard A
Typing for MLC determinants by means of LD-homozygous and LD-heterozygous test cells.
Transplantation proceedings 1973;5(4):1543-9.
1973: Dupont B; Jersild C; Hansen G S; Nielsen L S; Thomsen M; Svejgaard A
Multiple MLC (LD) determinants on the same HL-A haplotype.
Transplantation proceedings 1973;5(4):1481-7.
1973: Jersild C; Fog T; Hansen G S; Thomsen M; Svejgaard A; Dupont B
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.
Lancet 1973;2(7840):1221-5.
1973: Jersild C; Platz P; Thomsen M; Hansen G S; Svejgaard A; Dupont B; Fog T; Ciongoli A K; Grob P
Letter: Transfer-factor therapy in multiple sclerosis.
Lancet 1973;2(7842):1381-2.
1973: Ballow M; Dupont B; Good R A
Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor.
The Journal of pediatrics 1973;83(5):772-80.
1973: Ciongoli A K; Platz P; Dupont B; Svejgaard A; Fog T; Jersild C
Letter: Lack of antigen response to myxoviruses in multiple sclerosis.
Lancet 1973;2(7838):1147.
1973: Dupont B; Andersen V; Ernst P; Faber V; Good R A; Hansen G S; Henriksen K; Jensen K; Juhl F; Killmann S A; Koch C; Muller-Berat N; Park B H; Svejgaard A; Thomsen M; Wiik A
Immunologic reconstitution in severe combined immunodeficiency with HL-A-incompatible bone marrow graft: donor selection by mixed lymphocyte culture.
Transplantation proceedings 1973;5(1):905-8.
1972: Dupont B; Andersen V; Hansen G S; Svejgaard A
Abnormal mixed lymphocyte reactions in the family of a patient with severe combined immunodeficiency.
Transplantation 1972;14(5):557-63.
1972: Dupont B; Jersild C; Jakobsen B
Elimination of non-viable cells by DNase treatment prior to lymphocytotoxicity test.
Tissue antigens 1972;2(2):141-4.
1971: Dupont B; Nielsen L S; Svejgaard A
Relative importance of Four and LA loci in determining mixed-lymphocyte reaction.
Lancet 1971;2(7738):1336-40.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Bo Dupont

Research Profile (preview)

Chemicals & Drugs

Physiology

Procedures

Anatomy

Genes & Molecular Sequences

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Bo Dupont (preview)

All Publications